Open Site Navigation

Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1

Source: EMBO Reports (2019)


Colorectal cancer (CRC) is the second leading cause of cancer death

in the United States, affecting 1 in 20 individuals. CRC has long

been recognized to result from host mutations that accumulate over

time, developing from pre-cancerous adenomatous polyps into

adenocarcinoma over approximately 10 years.


Fusobacterium nucleatum promotes colorectal cancer
.pdf
Download PDF • 3.85MB

©2022 by Direct Diagnostics LLC. Direct Diagnostics is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, and meets the requirements to perform high complexity tests. CLIA Registration 45D2190910. 

Direct Diagnostics is certified under the College of American Pathologists (CAP), CAP Accreditation #9088531

Website by Redwood Designs.

  • Instagram
  • LinkedIn | Direct Dx
  • Facebook
  • YouTube